Unusual Horner's Syndrome in Recurrent Breast Cancer: Evaluation Using 18F-FDG PET/CT.

about

Biopsy from Recurrent Lesion May Change Further Treatment Plan in Metastatic Breast Cancer.

P2860

Q48354643-9A2FB697-88B7-41B9-9CE1-27D45EB2AAEE

P2860

Unusual Horner's Syndrome in Recurrent Breast Cancer: Evaluation Using 18F-FDG PET/CT.

Item

http://www.wikidata.org/entity/Q47843410

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Unusual Horner's Syndrome in Recurrent Breast Cancer: Evaluation Using 18F-FDG PET/CT.

@en

Unusual Horner's Syndrome in Recurrent Breast Cancer: Evaluation Using 18F-FDG PET/CT.

@nl

type

Item

label

Unusual Horner's Syndrome in Recurrent Breast Cancer: Evaluation Using 18F-FDG PET/CT.

@en

Unusual Horner's Syndrome in Recurrent Breast Cancer: Evaluation Using 18F-FDG PET/CT.

@nl

prefLabel

Unusual Horner's Syndrome in Recurrent Breast Cancer: Evaluation Using 18F-FDG PET/CT.

@en

Unusual Horner's Syndrome in Recurrent Breast Cancer: Evaluation Using 18F-FDG PET/CT.

@nl

P1476

Unusual Horner's Syndrome in Recurrent Breast Cancer: Evaluation Using 18F-FDG PET/CT.

@en

P2093

Sohyun Park

http://www.w3.org/2001/XMLSchema#string

Tae Sung Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Horner syndrome.

Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012.

Diagnosis and management of central nervous system metastases from breast cancer.

The response to neoadjuvant chemotherapy predicts clinical outcome and increases breast conservation in advanced breast cancer

Patterns of Recurrence and outcome according to breast cancer subtypes in lymph node-negative disease: results from international breast cancer study group trials VIII and IX.

Performance of FDG PET/CT in the clinical management of breast cancer.

¹⁸F-FDG PET/CT for Staging and Restaging of Breast Cancer.

The Prognostic Value of (18)F-FDG PET/CT for Early Recurrence in Operable Breast Cancer: Comparison with TNM Stage.

Evaluation of the causes and accuracy of pharmacologic localization in Horner's syndrome.

P2888

s13139-016-0437-6

P304

93-96

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1007/S13139-016-0437-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Seok-Ki Kim

P577

2016-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28250864

http://www.w3.org/2001/XMLSchema#string

P932

5313462

http://www.w3.org/2001/XMLSchema#string

Unusual Horner's Syndrome in Recurrent Breast Cancer: Evaluation Using 18F-FDG PET/CT.

about

P2860

P2860

Unusual Horner's Syndrome in Recurrent Breast Cancer: Evaluation Using 18F-FDG PET/CT.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P932